Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Back
Evaluation ViewAttendees 10

Hematology/Oncology
Session Type: Oral Abstract

Hematology/Oncology

Monday, April 28, 2025
2:00pm – 3:30pm HST
Location: Convention Center: 327
CE: 1.5

Disclosure(s):
E. Vincent Faustino, MD, MHS: Dexcom (Terminated, November 30, 2022) (Products/Services: Advisory Committee); Diagnostica Stago (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Grifols Shared Services of North America (Terminated, January 23, 2024) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Jordan Shavit, MD, PhD: No relevant disclosure to display
Patrick McGann, MD PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

  • 2:00pm – 2:15pm HST
    Quantifying the Absolute Time-Dependent Risk of Pediatric Hospital-Acquired Venous Thromboembolism

    Presenting Author: Maya K. Raad, MD (she/her/hers) – Yale School of Medicine

  • 2:15pm – 2:30pm HST
    Evaluating Secretory Phospholipase A2 (sPLA2) during Vaso-occlusive Pain Episodes (VOE) in Hospitalized Patients with Sickle Cell Disease (SCD)

    Presenting Author: Rawan Korman, MD (she/her/hers) – Emory University School of Medicine

  • 2:30pm – 2:45pm HST
    The potential of BCL-xL degradation as a strategy to eliminate chemotherapy-resistant neuroblastoma persister cells

    Presenting Author: Matteo Calafatti, MD (he/him/his) – Boston Children's Hospital / Boston Medical Center

  • 2:45pm – 3:00pm HST
    Spatial Transcriptomic Analysis of Pediatric Thyroid Cancer Samples Reveals Distinct Macrophage Infiltrate in Areas of Tumor Invasion

    Presenting Author: Megan L. Tigue, B.A. (she/her/hers) – Vanderbilt University School of Medicine

  • 3:00pm – 3:15pm HST
    Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models

    Presenting Author: Alison C. Livada, PhD (she/her/hers) – University of Rochester

  • 3:15pm – 3:30pm HST
    The Zika Viral Therapy of Metastatic High-Risk Neuroblastoma In Vivo Models yields effective Tumor Elimination when Applied to Permissive Host Cells

    Presenting Author: Joseph Mazar, PhD – Nemours Children's Health